Human phospholipases
US7368270B2 · kind B2 · utility
0Cited by
5References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2006 |
| Grant date | May 6, 2008 |
| Priority date | — |
| Expiry date | Mar 7, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/6883
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.